Skip to main content
. 2020 Oct 14;11(10):857. doi: 10.1038/s41419-020-03045-0

Fig. 4. Western blot and cell viability analyses of huc-MSCs.

Fig. 4

Protein bands and protein expressions of huc-MSCs with PL treatment (A) and with PL plus BECLIN1-siRNA (siBeclin1) treatment (B). Cell viability of huc-MSCs with PL and siBeclin1 treatment at 24 and 48h (C). siNC: nontargeting control siRNA-treated group; siBeclin1: BECN1-siRNA-treated group. Data are mean values ± SD. Different symbols (a, b, and c) indicate significant difference among groups [Fisher’s least significant difference (LSD), P < 0.05], and the values decrease with the order from a to c.